Connect with colleagues at the Basic Research Conference (BRC) and the Clinical Research Conference (CRC) pre-meeting courses at the 2016 ACR/ARHP Annual Meeting! The ACR has an exceptional array of research leaders lined up for this year’s BRC and CRC sessions on Friday, Nov. 11, and Saturday, Nov. 12 in Washington, D.C. Get ready to…
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

Preceptorships, Mentors Steer Rheumatology
Brian Le, MD, a rheumatology fellow at the Medical College of Georgia at Augusta University (MCG), credits an excellent mentor and two Rheumatology Research Foundation preceptorships with guiding his career toward rheumatology. “Working with Dr. Laura Carbone has opened up a lot of doors for me,” says Dr. Le. “I wouldn’t have such a great relationship with…

Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology
Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The…
Bipartisan RheumPAC Serves Needs of Patients and Rheumatologists
For more than a decade, the ACR’s Government Affairs Committee (GAC) has given rheumatologists a voice in the halls of Congress. Since 2007, that voice has been amplified by RheumPAC, the bipartisan political action committee for ACR/ARHP members that helps advance the policy goals of the College, rheumatology professionals and their patients. “RheumPAC allows us…
Advocates on the Hill
On Sept. 12–13, nearly 100 rheumatologists, health professionals and patients participated in the Advocates for Arthritis event on Capitol Hill to advocate on behalf of those living with and treating rheumatic diseases. Key Requests & Congressional Support Attendees visited 116 members of Congress and their staff members to: Advocate for changes to the Centers for…
Tenet Healthcare to Pay More Than $513 Million in Fraud Scheme
WASHINGTON (Reuters)—U.S. hospital chain Tenet Healthcare Corp. and two of its Atlanta-area units will pay more than $513 million to resolve criminal charges and civil claims relating to a scheme to defraud the U.S. and pay kickbacks in exchange for patient referrals, the U.S. Department of Justice said on Monday.1 Tenet had disclosed in August…
Big Pharma vs. Big Pharma in Court Battles over Biosimilar Drugs
ZURICH (Reuters)—The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovative treatments queue up to peddle copies of rivals’ complex biological medicines. These drug makers are now increasingly straddling both sides of the courtroom, too, protecting their high-price products from biosimilars—biopharmaceutical drugs with the treatment properties of medicines…
Pregnancy Outcome in Early Rheumatic Disease
Systemic autoimmune rheumatic diseases are associated with increased rates of adverse pregnancy outcomes, including spontaneous abortion, preeclampsia, fetal growth restriction (FGR) and prematurity. In this study population, preclinical rheumatic disorders were associated with an increased risk of FGR, preeclampsia and small-for-gestational-age infants. The impact of these findings and their utility in screening for fetal growth restriction/preeclampsia need to be confirmed in population studies…

Diagnostic Criteria, Classification Lacking for Vasculitis; New Research in Treatment for Systemic Sclerosis
LONDON—Despite the detailed terminology for describing vasculitis established by the Chapel Hill Consensus (CHC) in 2012, the field badly needs better classification and diagnostic criteria for the group of diseases, an expert said in a presentation at the Annual Congress of the European League Against Rheumatism (EULAR 2016). It’s a topic that is now being…

Research on Ixekizumab in Psoriatic Arthritis and More Presented at EULAR 2016
LONDON—Results from the extension phase of a Phase 3 trial for the IL-17A inhibitor ixekizumab in psoriatic arthritis (PsA) show that patients started on placebo, adalimumab and ixekizumab continued to show improvements in arthritis, dactylitis and ethesitis, said Philip Mease, MD, a rheumatologist at Swedish Medical Center University of Washington in Seattle.1 Dr. Mease presented the…
- « Previous Page
- 1
- …
- 138
- 139
- 140
- 141
- 142
- …
- 250
- Next Page »
